Genetic profiling could help tailor hormone therapy for prostate cancer after surgery

3 weeks ago 5
A caller investigation of the NRG-RTOG 0534 "SPPORT" objective proceedings evaluated the Luminal B (LumB) molecular subtype utilizing the PAM50 genomic classifier to find whether tumor biology could assistance place patients astir apt to payment from hormone therapy.
Read Entire Article